Impacts of in vivo and in vitro exposures to tamoxifen: comparative effects on human cells and marine organisms

Tamoxifen (TAM) is a first generation-SERM administered for hormone receptor-positive (HER+) breast cancer in both pre- and post-menopausal patients and may undergo metabolic activation in organisms that share similar receptors and thus face comparable mechanisms of response. The present study aimed...

ver descrição completa

Detalhes bibliográficos
Autor principal: Fonseca, T. G. (author)
Outros Autores: Carriço, T. (author), Fernandes, E. (author), Abessa, D. M. S. (author), Tavares, A. (author), Bebianno, M. (author)
Formato: article
Idioma:eng
Publicado em: 2020
Assuntos:
Texto completo:http://hdl.handle.net/10400.1/13685
País:Portugal
Oai:oai:sapientia.ualg.pt:10400.1/13685